Ardent Health Partners, LLC
NYSE:ARDTMedical - Care Facilities
-$0.14 today
- Market cap
- $2.03B
- Beta
- 0.84
- P/E (TTM)
- 9.4
- EPS (TTM)
- $0.95
Volume 7.27M
Average 0.45M
ARDT EBITDA Margin
EBITDA as a percentage of revenue.
Ardent Health Partners, LLCNYSE: ARDT
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin holds steady near 8.0%
EBITDA Margin was 8.0% in Q1 FY2026, down 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 7.9%, down 1.5 pp year over year. Over 3 fiscal years it narrowed by 2.5 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 6.4% for the fiscal year ending Dec 2026, down from 7.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 8.0%-1.1 pp QoQ
- Last fiscal yearDec 2025
- 7.9%-1.8 pp YoY
- LTMMar 2026
- 7.9%-1.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.3 pp | -5.3 pp | -4.9 pp |
| 1 year | -1.8 pp | -1.4 pp | +0.3 pp |
| 3 years | -2.5 pp | -0.9 pp | +1.6 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 7.9%
- Year-over-year change
- -1.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.9% | -1.8pp |
| FY2024 | 2024-12-31 | 9.6% | +3.2pp |
| FY2023 | 2023-12-31 | 6.5% | -3.9pp |
| FY2022 | 2022-12-31 | 10.4% | -0.5pp |
| FY2021 | 2021-12-31 | 10.8% | — |
EBITDA Margin vs competitors
How ARDT compares with its peers on the latest reported figures
- ARDT's LTM Mar 2026 EBITDA Margin of 7.9% is the 8th highest of the 11 companies compared; the peer median is 10.4%.
- Its year-over-year change of -1.5 pp is the 9th highest of 11, against a peer median of +0.0 pp.
- Over three fiscal years its change of -2.5 pp compares with a peer median of +4.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 14.0% | -0.5 pp | -0.2 pp | |
| LTM Sep 2026 | 13.1% | +0.5 pp | +7.7 pp | |
| LTM Oct 2026 | 13.0% | +1.4 pp | +40.8 pp | |
| LTM Sep 2026 | 12.8% | -0.7 pp | +6.4 pp | |
| LTM Jun 2026 | 11.3% | +0.7 pp | +2.0 pp | |
| LTM Mar 2026 | 9.4% | +1.7 pp | -0.3 pp | |
| LTM Jun 2026 | 8.3% | +4.0 pp | +22.2 pp | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | 7.9% | -1.5 pp | -2.5 pp |
| LTM Mar 2026 | 4.6% | -1.1 pp | -5.5 pp | |
| LTM Sep 2026 | -19.5% | -33.4 pp | -43.8 pp | |
| LTM Sep 2026 | -550.8% | -269.0 pp | +146419.7 pp | |
| Peer median (excluding ARDT) | 10.4% | +0.0 pp | +4.2 pp | |
Competitors are the stored peer set for ARDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.87B | 5.13B | 5.41B | 5.97B | 6.32B |
| Cost of Revenue | 927.33M | 955.17M | 140.84M | 1.03B | 155.7M |
| Gross Profit | 3.94B | 4.17B | 5.27B | 4.93B | 6.17B |
| Gross Margin | 81.0% | 81.4% | 97.4% | 82.7% | 97.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.13B | 3.37B | 3.62B | 3.88B | 1.19B |
| Operating Expenses | 3.51B | 3.96B | 5.04B | 4.53B | 5.84B |
| Depreciation & Amortization | 137.2M | 138.17M | 140.84M | 146.29M | 155.7M |
| EBITDA | 526.93M | 531.7M | 350M | 574.93M | 497.26M |
| EBITDA Margin | 10.8% | 10.4% | 6.5% | 9.6% | 7.9% |
| Operating Income | 436.56M | 217.03M | 229.5M | 405.76M | 325.58M |
| Operating Margin | 9.0% | 4.2% | 4.2% | 6.8% | 5.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 93.83M | 82.05M | 65.43M | 65.58M | 55.2M |
| Other Income / Expenses | (140.68M) | 94.45M | (77.89M) | (42.7M) | (39.23M) |
| Income Before Tax | 295.89M | 311.48M | 151.61M | 363.06M | 286.36M |
| Pre-Tax Margin | 6.1% | 6.1% | 2.8% | 6.1% | 4.5% |
| Income Tax Expense | 51.31M | 46.11M | 22.64M | 63.35M | 56.22M |
| Net Income | 154.26M | 188.91M | 50.29M | 210.34M | 135.81M |
| Net Margin | 3.2% | 3.7% | 0.9% | 3.5% | 2.1% |
| EPS (Basic) | 1.08 | 1.32 | 0.35 | 1.59 | 0.96 |
| EPS (Diluted) | 1.08 | 1.32 | 0.35 | 1.58 | 0.96 |
| Weighted Avg Shares | 143.26M | 143.26M | 143.26M | 132.44M | 140.76M |
| Weighted Avg Shares (Diluted) | 143.26M | 143.26M | 143.26M | 132.75M | 141.45M |
Ardent Health Partners, LLC
NYSE:ARDT
Intrinsic Alpha fair value
Locked
Current Price
$14.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.